August 2025

Week in Review: Self-expanding stents recalled | PFA & phrenic nerve damage | Doc heads to prison | Thanking Taylor Swift ()
Patient's death prompts new FDA warning | Previewing ESC 2025 | Multiple Class I recalls | Palliative care's impact ()
J&J MedTech hit with permanent injunction | Medtronic TAVR valves gain a new FDA approval | PPMI after TTVR ()
New issue with heart pump controllers linked to patient death | AI detects risk of high Lp(a) levels | A sneak peak of TCT 2025 ()
News Alert: FDA details new risk with heart pump controllers after patient’s death ()
Oral GLP-1 drug linked to more positive data | Nuclear cardiology & cardiac amyloidosis | New York cardiologist headed to prison ()
FDA announces recall of self-expanding stents | Celebrating the STS/ACC TVT Registry | Thanking Taylor Swift | Abbott's big news ()
How CCTA could make ICA a thing of the past | Positron makes a move | New LAAO guidelines: 6 key takeaways ()
PFA linked to risk of phrenic nerve damage | Cardiology practices must be more sustainable | Positron finds a new home ()
Week in Review: A safety risk with Medtronic catheters | New hypertension guidelines | Be prepared for cath lab complications ()
How the economy is reshaping cardiac care | Heartflow raises $364M, rings Nasdaq opening bell | Cardiologist pay stays steady ()
FDA clears CCTA AI plaque assessment | Former surgeon general joins Eko | Boston Scientific launches stents vs. DCB trial ()
FTC challenge to Edwards JenaValve acquisition may delay FDA clearance | Cardiology tops FDA breakthough devices | Mo99 supply ()
How to prepare for cath lab complications | Progress for a new PAH drug | TAVR & BAV stenosis | PDA closure in premature infants ()
Device safety issues for Boston Scientific | Early rhythm control boosts outcomes | EP catheters recalled | Drug candidate fails ()
Insulin pump error linked to 700 adverse events | Hemodynamic deterioration 1 year after TAVR ()
Stroke risk after TAVR | The top hospitals for cardiology, heart surgery & vascular surgery | New SCAI guidelines ()
Safety issue could lead to a device shortage | New ACC/AHA hypertension guidelines | Gene research links kidney health to CVD ()
Most popular cardiology video interviews this past month ()
Week in Review: A big win for Lilly | Heart pump accessories recalled | How Lp(a) tests could transform care | Doc to pay $1.2M ()
Oral GLP-1 drug impresses | The power of prevention | Cannabis use in older patients | Drinking habits & heart health ()
News Alert: FDA shares new safety concern with Medtronic catheters ()
Heart pump accessories recalled | Is it time for universal Lp(a) screening? | Long-term survival after mitral valve surgery ()
Air embolism risk linked to 17 deaths | IVL complications are rare | 'Encouraging' PCI data | Medicare covers TriClip ()
Palliative care & heart failure | IVL for mitral valve disease | New coronary sinus reducer data | $32M for LAAO tech ()
FDA details device recalls | A new technique for robotic AVR | CABG or PCI? | Surgeon pay takes a hit ()
AI fueling more & more cardiology tech | Heartflow rings opening bell | High costs may limit access | ACC takes on pericarditis ()
The best heart hospitals in the United States | Key takeaways from new LAAO guidelines | Choosing between CABG & PCI ()
How cardiologists can boost surgery volumes | Spreading the word about CKM syndrome | Fitness trackers & cardiovascular health ()
CMS proposes a pay bump | Watchman safety concerns | EP catheters recalled | ASNC calls on Congress | Medicare coverage for RDN ()
Oral GLP-1 drug linked to weight loss, cardiovascular benefits | Cardiologist agrees to pay $1.2M | Air purifiers vs. pollution ()
Week in Review: FDA shares major device warnings | Cardiologist salary update | IT systems keep evolving | New LAAO guidelines ()
The evolution of cardiovascular IT systems | Too much screen time is bad for the heart | FDA approves new liquid embolic agent ()
Medicare covers TriClip | Pascal system linked to key benefits after M-TEER, T-TEER | Pairing SAVR with other heart surgeries ()
A new Watchman risk | FTC challenges medtech deal | Catheters recalled | Safety issue linked to 16 deaths | AI for HF screening ()
News Alert: FDA highlights 2 new safety issues with Boston Scientific devices ()
TAVR Highlights: Stroke rate still higher for women | Colchicine reduces risks | New device impresses | FDA clears AI software ()
How economic forces are changing cardiac care | Key takeaways from new LAAO guidelines | AI specialists raise $55M ()
July's Top Stories: FDA clears OTC cuffless BP monitor | Trump's health | The top US heart hospitals | Surgical device recalls ()
The first robotic surgery of its kind | New data on using Pascal for M-TEER & T-TEER | Good news for Boston Scientific ()
Cardiology still a leader in AI | Taking risk assessments to another level | FDA clears software for real-time TAVR guidance ()
New salary data for cardiologists, surgeons & more | Same-day PPMI after TAVR | Early rhythm control in high-risk patients ()
Week in Review: The best heart hospitals in the US | CCTA vs. ICA | FDA announces new recall | Drug candidate for AFib fails ()
Tirzepatide provides clear cardiovascular protection | Same-day discharge for ACS PCI patients | Top studies at ESC ()